NDC 0054-0603 – Desvenlafaxine
Desvenlafaxine Succinate 25 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC0054-0603
Product details
- Brand name
- Desvenlafaxine
- Generic name
- Desvenlafaxine
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA204083
- Marketed since
- August 29, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Active ingredients
- Desvenlafaxine Succinate 25 mg/1
Uses, dosage, side effects and warnings for Desvenlafaxine →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0054-0603-13 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0054-0603-13) | Aug 29, 2017 |
Other Desvenlafaxine products
- 50090-4806 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · A-S Medication Solutions
- 60687-607 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · American Health Packaging
- 71335-1700 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 63629-7524 Desvenlafaxine Succinate 25 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 0054-0400 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · Hikma Pharmaceuticals USA Inc.
- 0054-0401 Desvenlafaxine Succinate 100 mg/1 · Tablet, Film Coated, Extended Release · Hikma Pharmaceuticals USA Inc.
- 50090-5293 Desvenlafaxine Succinate 50 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-5274 Desvenlafaxine Succinate 25 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7190 Desvenlafaxine Succinate 25 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7737 Desvenlafaxine Succinate 50 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6738 Desvenlafaxine Succinate 25 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 0591-4060 Desvenlafaxine Succinate 25 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.